Dermatitis, Irritant: Clinical Trials

6 trials for Dermatitis, Irritant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 16Completed 6

Follow Dermatitis, Irritant: new trials by email Literature Review of Dermatitis, Irritant trials Research Report on Dermatitis, Irritant

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety Evaluation of KX01 Ointment 1% in Japanese Healthy Male Subjects
KX01 ointment 1%, Placebo ointment - Healthy Volunteer
Phase 1CompletedPharmaEssentia202021-11-162022-02-18
Evaluation of Potential Phototoxicity Skin Reaction After Use of MC2-01 Cream
MC2-01 Cream, irradiation, MC2-01 Cream, no irradiation, MC2-01 vehicle, irradiation - Phototoxicity
Phase 1CompletedMC2 Therapeutics352019-02-272020-02-12
TMC435-TiDP16-C125 - Study in Healthy Volunteers to Evaluate the Potential of TMC435 to Increase the Sensitivity of the Skin Towards Exposure to Sun Light
TMC435, Placebo, Ciprofloxacin - Hepatitis C Virus
Phase 1CompletedTibotec Pharmaceuticals, Ireland492010-07-012013-05-06
A Study to Evaluate the Potential of Tazarotene Foam to Cause a Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers
Tazarotene Foam without irradiation, Tazarotene Foam with UVA and UVB irradiation, Tazarotene Foam with UVA, UVB, and visible light - Acne Vulgaris
Phase 1CompletedStiefel, a GSK Company382010-04-012017-06-20
Clinical Evaluation of the Phototoxic Potential of Xenaderm Ointment
Xenaderm, Placebo - Healthy
Phase 1CompletedHealthpoint382008-02-012014-01-13
Clinical Evaluation of the Photoallergy Potential of Atralin Gel
Atralin (tretinoin) gel, 0.05% - Healthy
Phase 1CompletedCoria Laboratories, Ltd.402008-01-012008-05-06

Narrower conditions

Dermatitis, Phototoxic (6)  ·  Acne Vulgaris (1)  ·  Hepatitis C (1)  ·  Photosensitivity Disorders (1)

Broader conditions

Dermatitis (6)  ·  Dermatitis, Contact (6)  ·  Skin Diseases (6)  ·  Skin Diseases, Eczematous (6)  ·  Skin and Connective Tissue Diseases (6)  ·  Photosensitivity Disorders (5)  ·  Acneiform Eruptions (1)  ·  Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  Digestive System Diseases (1)  ·  Flaviviridae Infections (1)  ·  Hepatitis (1)  ·  Hepatitis, Viral, Human (1)  ·  Infections (1)

Interventions

Radiation (2)  ·  Ciprofloxacin (1)  ·  Gels (1)  ·  Granulex (1)  ·  Light (1)  ·  Simeprevir (1)  ·  Tretinoin (1)

Sponsors

Coria Laboratories, Ltd. (1)  ·  Healthpoint (1)  ·  MC2 Therapeutics (1)  ·  PharmaEssentia (1)  ·  Stiefel, a GSK Company (1)  ·  Tibotec Pharmaceuticals, Ireland (1)

Countries

United States (3)  ·  Japan (1)

Top investigators

Hisakuni Sekino (1)  ·  Innes Cargill, PhD (1)  ·  Jonathan S Dorsik (1)  ·  Joseph W Stanfield, MS (1)